Is Summit Therapeutics Inc. (SMMT) a Buy, Sell, or Hold?
NASDAQ : SMMT
Summit Therapeutics Inc. — Competitors
$13.105 USD
-$0.56 (-4.06%)
- Volume
- 4.23M
- Average Volume
- 5.25M
- Market Capitalization
- $10.17B
- P/E Ratio
- -11.70
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $30.98
- Year Low
- $12.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.96
SMMT vs. The Competition
| Properties | SMMT | ASND | BBIO | EXAS |
|---|---|---|---|---|
| Market Cap | $10.17B | $15.74B | $16.48B | $20.03B |
| Shares Outstanding | $776.16M | $62.11M | $195.86M | $190.89M |
| P/E Ratio | -11.7 | 27.22 | -22.43 | -95.69 |
| EPS | -1.1 | 8.21 | -3.73 | -1.1 |
| Day Low | 13.1 | 253.0475 | 83.98 | 104.91 |
| Day High | 14.23 | 258.58 | 86.22 | 104.91 |
| Year Low | 12.55 | 160.86 | 42.09 | 38.81 |
| Year High | 30.98 | 282.15 | 93.415 | 104.98 |
| Average Price 50 | 15.1878 | 243.624 | 72.5281 | 103.023 |
| Average Price 200 | 17.28975 | 225.20688 | 70.6848 | 74.2944 |
| Volume | 4.23M | 360.57K | 2.19M | 21.56M |
| Average Volume | - | - | - | - |